Get ready to discover the eagerly anticipated third quarter financial results of Alnylam Pharmaceuticals (NASDAQ: ALNY) on Thursday 31st October 2024. This significant announcement is scheduled to take place before market open, giving investors and analysts a chance to gain valuable insights into the company's financial performance.
Financial analysts on Wall Street are predicting that the concern is about to reveal an estimated $0.93 loss per share for the quarter. Additionally, the company is projected to announce a total revenue of $533.1 million for this period.
In the preceding quarter of the previous year, the company shared its financial results, revealing that it had income of $1.74 per share.
Wall Street analysts have offered their forecasts for the company's yearly performance, predicting a total revenue of $2.23 billion. At the same time, they are expecting the company to achieve per share loss of $2.39 for the fiscal year ahead.
The business has scheduled a conference call on 31st October 2024 at 08:30 AM eastern time to discuss Q3 financial results.
Throughout Tuesday's trading, Alnylam Pharmaceuticals (ALNY) shares fluctuated between $282.22 and $287.02, with a trading volume of 701.90 thousand shares. The stock ended the regular trading session at $284.69, showing drop of 0.77 percent.
